Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance.

Acquier, M; Taton, B; Alain, S; Garrigue, I; Mary, J; Pfirmann, P; Visentin, J; Hantz, S; Merville, P; Kaminski, H; Couzi, L.

Afiliação

Acquier M; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.
Taton B; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.
Alain S; National Reference Center for Herpes Viruses, Virology Department, Limoges University Hospital, LimogesFrance.
Garrigue I; UMR INSERM U1092, RESINFIT, Limoges University, LimogesFrance.
Mary J; Laboratory of Virology, Bordeaux University Hospital, Bordeaux, France.
Pfirmann P; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.
Visentin J; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.
Hantz S; CNRS-UMR 5164 ImmunoConcEpT, Bordeaux University, Bordeaux, France.
Merville P; Laboratory of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France.
Kaminski H; National Reference Center for Herpes Viruses, Virology Department, Limoges University Hospital, LimogesFrance.
Couzi L; UMR INSERM U1092, RESINFIT, Limoges University, LimogesFrance.